What is Melphalan-prednisone-bortezomib (VMP or MPB)?
CATEGORY:
Melphalan-prednisone-bortezomib, also known as VMP or MPB, is a regimen that may be used for the treatment of multiple myeloma in patients that are not candidates for a stem cell transplant. It contains the anticancer agents bortezomib and melphalan along with prednisone, a corticosteroid.
Save up to 80% off your prescriptions!
How do members experience Melphalan-prednisone-bortezomib (VMP or MPB)?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple myeloma | 141 | 4 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Peripheral neuropathy | 2 | |
| Dizziness with hypotension upon standing | 1 | |
| Weight gain | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 2 |
Learn more about our community’s experience with Melphalan-prednisone-bortezomib (VMP or MPB)
What are people saying about Melphalan-prednisone-bortezomib (VMP or MPB)?
148
148
members have reported taking Melphalan-prednisone-bortezomib (VMP or MPB)
Join the conversation and connect with people who have taken Melphalan-prednisone-bortezomib (VMP or MPB)
Last updated: